Treatment pathways and associated costs of metastatic colorectal cancer in Greece.
Ioannis SougklakosElias AthanasiadisIoannis BoukovinasMichalis KaramouzisAggelos KoutrasPaulos PapakotoulasDimitra LatsouDimitra LatsouEugena StamuliAthanasios BalasopoulosAggelos SiderisPublished in: Cost effectiveness and resource allocation : C/E (2022)
mCRC is a societal challenge for healthcare systems as the treatment is more prolonged but expand patients' survival. Thus, reimbursement decisions should be based not just on the cost of the treatment, but on the magnitude of the benefit of its treatment on patients' survival and quality of life.